lct featured on sky tv news, page-2

It all seems good, LCT have money in the bank and steady stream , some high calibre people leading the various clinical trials, international exposure in multiple markets and trials ongoing or planned in two biggest opportunity areas going -Diabetes and Parkinsons with potential others in the background. The management team seem to be doing a great job in getting global exposure also' so have high hopes for this stock. I for one am copying the founding director and accumulating regularly at these levels. Still risk of course but the potential returns are definetly worth it for me. I am amazed the stock hasnt climbed on the two bits of recent news.... but just means more buying opportunities. I think it was about two to three years ago those happy pigs were on the TV in the first airing and the stock price got to about a top of 38 cents. Here we are a few years further down the clinical trial track and sitting down at 5 cents- but lots more pigs, backers and trials well on the way now so much closer to possible commercialisation. Bargain.